viral hepatitis, hepatic infarction, and various forms of chronic liver disease (Methods in the online-only Data Supplement). This algorithm has 99.5% specificity and 80.2% positive predictive value for identifying liver disease. 5 We also separately examined liver cirrhosis-both alcohol related and nonalcohol related (Methods in the online-only Data Supplement).
The primary outcome was discharge disposition assessed on an ordinal scale consisting of discharge to home, discharge to any institution (nursing or rehabilitation facility), or in-hospital death. This measure is a good surrogate for functional outcomes as measured by the modified Rankin Scale at 3 or 12 months after stroke. 6 The secondary outcome was in-hospital mortality.
Statistical Analysis
Baseline variables between groups were compared with the t test or χ 2 test as appropriate. The association between liver disease and discharge disposition was analyzed with ordinal logistic regression. In a secondary analysis, we used multiple logistic regression to assess the association between liver disease and in-hospital mortality versus discharge to any location. Both analyses were adjusted for potential confounders: demographic variables, vascular diseases, and their risk factors (Methods in the online-only Data Supplement), alcohol use, and the Elixhauser Index. The Elixhauser Index can be used to reliably adjust estimates of in-hospital mortality risk after stroke for comorbidity burden. 7 In addition, interaction terms were used to analyze whether the association between liver disease and discharge disposition varied by stroke type (ischemic versus hemorrhagic). All covariates were included independent of statistical significance to maximally isolate the contribution of exposure. The threshold of statistical significance allowed for an α-error of 0.05. All analyses were performed by HK using Stata/MP (version 13; College Station, TX).
Results

Patient Characteristics
We identified 121 428 patients with ICH and 703 918 patients with ischemic stroke. Patients with ICH were younger than those with ischemic stroke, had lower rates of traditional vascular risk factors, and had higher rates of liver disease and overt coagulopathy ( Table I in the online-only Data Supplement). Liver disease was documented in 13 584 (1.7%) patients and cirrhosis in 6568 (0.8%) patients. Of patients with ICH, 3443 (2.8%) patients had liver disease and 2066 (1.7%) had cirrhosis. For ischemic stroke, 10 141 (1.4%) had liver disease and 4502 (0.6%) had cirrhosis. Patients with liver disease were younger than those without liver disease; had higher rates of alcohol abuse and overt coagulopathy, and lower rates of hypertension (Table II in 
Primary Analysis
After ICH, 29.7% of patients were discharged home, 43.2% were discharged to a facility, and 27.1% died before discharge. Of patients with ischemic stroke, 48.4% were discharged home, 43.6% were discharged to a facility, and 8.0% died. After adjustment for demographics, vascular risk factors, and Elixhauser comorbidities in ordinal logistic regression models, liver disease was associated with worse discharge disposition after both ICH (global odds ratio [OR], 1.28; 95% CI, 1.19-1.38) and ischemic stroke (global OR, 1.23; 95% CI, 1.17-1.29). Cirrhosis, specifically alcohol-related cirrhosis, seemed more strongly associated with worse discharge disposition after ICH (OR, 1.51; 95% CI, 1.32-1.74) and ischemic stroke (OR, 1.63; 95% CI, 1.46-1.82; Table) . For all comparisons, interaction terms revealed no variation by stroke subtype in the association between liver disease and discharge disposition; in other words, liver disease was associated with worse discharge disposition to a similar extent after both ischemic and hemorrhagic stroke.
Secondary Analysis
The crude rates of in-hospital mortality after stroke were higher for patients with liver disease (Results in the onlineonly Data Supplement). After adjustment for covariates, liver disease was associated with in-hospital death after ICH (OR, 1.33; 95% CI, 1.23-1.44) and ischemic stroke (OR, 1.60; 95% CI, 1.51-1.71). Interaction terms revealed that liver disease was less strongly associated with in-hospital mortality after ICH than after ischemic stroke (P<0.001).
Discussion
In a large, heterogeneous cohort of patients with stroke, we found an independent association between liver disease and worse hospital discharge disposition and in-hospital death. This association seemed more pronounced in patients with alcohol-related cirrhotic liver disease. The impact of liver disease on hospital discharge disposition after stroke by ordinal analysis did not vary by stroke type. However, in secondary analysis, liver disease was more strongly associated with inhospital death after ischemic stroke than after ICH.
Our findings are consistent with a small, retrospective study that found increased in-hospital mortality after ICH in liver disease (OR, 7.4; 95% CI, 1.3-41.5). 8 In contrast to our cohort, this study was a single-center cohort of patients. 8 With respect to ischemic stroke outcomes, unlike a limited analysis of monoethnic patients with nonalcoholic fatty liver disease, 9 our findings suggest that liver disease is also associated with a worse outcome after ischemic stroke.
The observed influence of liver disease on discharge disposition after stroke may be multifactorial. Poor outcomes after ICH in this population may, in part, be because of increased hematoma size or expansion in patients with liver disease. 10, 11 Alternatively, patients with liver disease may be otherwise prone to decompensation because of non-neurological ICH indicates intracerebral hemorrhage. *Results are reported as the global odds ratio (95% confidence interval) by ordinal logistic regression for a worse outcome on an ordinal scale: discharge to home, discharge to institution, in-hospital mortality.
†Interaction term analysis compared the strength of association between liver disease and outcome after ICH vs ischemic stroke.
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conditions, 8 such as alcohol withdrawal or frailty. Last, possible interactions between liver disease and stroke treatment may play a role directly or limit provision of therapies.
Our study has several limitations. First, data on hematologic parameters, stroke severity, hematoma size, and antithrombotic medications were unavailable. These variables may mediate the observed association; therefore, it is not clear that they should be adjusted for in models. Second, given the reliance on inpatient International Classification of Diseases, 9th Revision, Clinical Modification diagnosis codes, ascertainment of liver disease and covariates may be incomplete. Similarly, some patients may have been included at the time of a recurrent and not first stroke. Imprecise ascertainment is expected to occur to a similar extent in the control group (patients without liver disease), but there may be differential ascertainment of some variables, such as alcohol abuse, which may cause residual confounding. Third, it is possible that some patients developed liver disease as a result of stroke treatment; however, this is expected to be rare as most liver diseases included are chronic, progressive disorders. Last, albeit a validated measure, 6 discharge disposition is a crude surrogate of functional outcome.
In summary, outcomes, including survival to discharge, after stroke are worse in patients with liver disease. Further research into the role of liver disease on stroke outcomes may lead to strategies to improve recovery in this vulnerable subset of patients.
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